Nephros (NEPH) Institutional Ownership $4.18 +0.03 (+0.72%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$4.16 -0.02 (-0.57%) As of 09/25/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nephros (NASDAQ:NEPH)CurrentInstitutional OwnershipPercentage41.10%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$855.51KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$145.76K Get NEPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Nephros stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NEPH Institutional Buying and Selling by Quarter Nephros Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Topline Capital Management LLC477,449$1.95M0.3%+13.1%4.504% 8/15/2025 Elkhorn Partners Limited Partnership14,500$59K0.0%-62.7%0.137% 8/8/2025 Geode Capital Management LLC93,187$381K0.0%+3.2%0.879% 5/12/2025Bard Associates Inc.143,221$246K0.1%-7.8%1.351% 2/14/2025Topline Capital Management LLC419,887$617K0.1%N/A3.984% 2/6/2025Bard Associates Inc.155,271$228K0.1%-9.9%1.473% 8/9/2024Dimensional Fund Advisors LP17,631$37K0.0%N/A0.167% 4/26/2024Mesirow Financial Investment Management Inc.15,383$34K0.0%N/A0.146% 2/10/2023Bard Associates Inc.194,789$225K0.1%-22.7%1.887% 11/15/2022Elkhorn Partners Limited Partnership50,341$46K0.0%+48.1%0.488% Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Bard Associates Inc.263,754$404K0.2%+7.0%2.556% 8/1/2022Cowen Prime Advisors LLC42,500$65K0.0%-47.1%0.412% 5/23/2022Cantor Fitzgerald L. P.12,813$56K0.0%N/A0.124% 5/11/2022Bard Associates Inc.246,408$1.08M0.4%+6.0%2.388% 5/10/2022Elkhorn Partners Limited Partnership23,712$104K0.1%+56.0%0.230% 5/2/2022Cowen Prime Advisors LLC80,400$354K0.1%-87.3%0.780% 2/19/2022Wexford Capital LP3,650,529$646.53M27.0%N/A35.674% 2/14/2022Elkhorn Partners Limited Partnership15,200$90K0.1%+78.8%0.149% 2/8/2022Cowen Prime Advisors LLC633,050$3.74M1.3%-4.1%6.186% 2/8/2022Samjo Capital LLC425,000$2.51M1.7%-22.7%4.153% 11/9/2021BlackRock Inc.18,079$158K0.0%-23.0%0.177% 11/2/2021Cowen Prime Advisors LLC660,150$5.79M2.2%+5.4%6.461% 8/17/2021Wexford Capital LP3,631,197$36.85M5.6%+1.9%35.541% 8/13/2021Vanguard Group Inc.99,936$1.01M0.0%+3.9%0.978% 8/12/2021Bard Associates Inc.231,508$2.35M0.8%+5.5%2.266% 8/2/2021Advisor Group Holdings Inc.4,574$46K0.0%+91,380.0%0.046% (Data available from 1/1/2016 forward) NEPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NEPH shares? During the previous two years, the following institutional investors and hedge funds held shares of Nephros shares: Topline Capital Management LLC ($1.95M), Geode Capital Management LLC ($381K), Bard Associates Inc. ($246K), Elkhorn Partners Limited Partnership ($59K), and Dimensional Fund Advisors LP ($37K), Mesirow Financial Investment Management Inc. ($34K).Learn more on Nephros' institutional investors. What percentage of Nephros' stock is owned by institutional investors? 41.10% of Nephros' stock is owned by institutional investors. Learn more on NEPH's institutional investor holdings. Which institutional investors have been buying Nephros' stock? The following institutional investors have purchased Nephros' stock in the last 24 months: Topline Capital Management LLC ($475.25K), Dimensional Fund Advisors LP ($17.63K), Mesirow Financial Investment Management Inc. ($15.38K), and Geode Capital Management LLC ($2.90K). How much institutional buying is happening at Nephros? Institutional investors have bought a total of 478,145 shares in the last 24 months. This purchase volume represents approximately $855.51K in transactions. Which of Nephros' major shareholders have been selling company stock? The following institutional investors have sold Nephros stock in the last 24 months: Bard Associates Inc. ($29.15K), and Elkhorn Partners Limited Partnership ($24.42K). How much institutional selling is happening at Nephros? Institutional investors have sold a total of 53,574 shares in the last 24 months. This volume of shares sold represents approximately $145.76K in transactions. Related Companies Neuronetics Institutional Ownership Anteris Technologies Global Institutional Ownership Nyxoah Institutional Ownership LENSAR Institutional Ownership Avita Medical Institutional Ownership Profound Medical Institutional Ownership Safe Pro Group Institutional Ownership Lakeland Industries Institutional Ownership Lucid Diagnostics Institutional Ownership Inovio Pharmaceuticals Institutional Ownership This page (NASDAQ:NEPH) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
